Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study.

Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA (2009) 5.22

The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol (2008) 5.05

Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ (2007) 2.93

Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging (2015) 2.84

Prevalence of abnormalities of electrocardiogram in old people. Br Heart J (1974) 2.31

Left ventricular mass and geometry and the risk of ischemic stroke. Stroke (2003) 2.15

Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) (1981) 1.99

Relation of QRS width in healthy persons to risk of future permanent pacemaker implantation. Am J Cardiol (2010) 1.97

Urban-rural differences in the prevalence of coronary heart disease and its risk factors in Delhi. Bull World Health Organ (1997) 1.63

Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload. Circulation (2015) 1.55

Cardiac remodeling at the population level--risk factors, screening, and outcomes. Nat Rev Cardiol (2011) 1.43

Prevalences of ECG findings in large population based samples of men and women. Heart (2000) 1.40

Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification. Int J Cardiovasc Imaging (2010) 1.35

The prevention of coronary heart disease in general practice. J R Coll Gen Pract (1980) 1.25

Ventricular arrhythmias in patients with myocardial infarction and ischaemia. Relationship to serum potassium and magnesium. Drugs (1984) 1.19

Ischaemic heart disease in the elderly. Br Heart J (1977) 1.07

Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study. Drugs (1988) 1.01

Cardiac proteasome activity in muscle ring finger-1 null mice at rest and following synthetic glucocorticoid treatment. Am J Physiol Endocrinol Metab (2011) 1.00

Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community. Cardiovasc Diabetol (2011) 1.00

Determinants of discrepancies in detection and comparison of the prognostic significance of left ventricular hypertrophy by electrocardiogram and cardiac magnetic resonance imaging. Am J Cardiol (2014) 0.96

Increased left ventricular mass as a predictor of sudden cardiac death: is it time to put it to the test? Circ Arrhythm Electrophysiol (2013) 0.94

Competing cardiovascular outcomes associated with electrocardiographic left ventricular hypertrophy: the Atherosclerosis Risk in Communities Study. Heart (2011) 0.94

Longitudinal study of heart disease in a Jamaican rural population. 3. Factors influencing changes in serial electrocardiograms. Bull World Health Organ (1972) 0.93

Anti-hypertensive drugs have different effects on ventricular hypertrophy regression. Clinics (Sao Paulo) (2010) 0.91

Significance of abnormalities of electrocardiogram in old people. Br Heart J (1974) 0.91

Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. Heart (1997) 0.90

Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality. Cardiovasc Drugs Ther (1994) 0.89

Second statement of the working group on electrocardiographic diagnosis of left ventricular hypertrophy. J Electrocardiol (2011) 0.88

Development and application of a longitudinal electrocardiogram repository: the Framingham Heart Study. J Electrocardiol (2012) 0.88

Left ventricular hypertrophy influences cardiac prognosis in patients undergoing dobutamine cardiac stress testing. Circ Cardiovasc Imaging (2010) 0.88

Left Ventricular Structure and Risk of Cardiovascular Events: A Framingham Heart Study Cardiac Magnetic Resonance Study. J Am Heart Assoc (2015) 0.87

Variable patterns of ST-T abnormalities in patients with left ventricular hypertrophy and normal coronary arteries. Br Heart J (1992) 0.85

Association of arterial stiffness and electrocardiography-determined left ventricular hypertrophy with left ventricular diastolic dysfunction. PLoS One (2012) 0.84

Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy. Br Heart J (1992) 0.84

The role of ECG in the diagnosis of left ventricular hypertrophy. Curr Cardiol Rev (2014) 0.84

Quantitative aspects of electrocardiograms of adults in a Jamaican rural population. Br Heart J (1973) 0.83

How reliable is the electrocardiogram in detecting left ventricular hypertrophy in hypertension? Postgrad Med J (1991) 0.83

30 Year patterns of mortality in Tobago, West Indies, 1976-2005: impact of glucose intolerance and alcohol intake. PLoS One (2011) 0.83

Electrocardiographic versus echocardiographic left ventricular hypertrophy and sudden cardiac arrest in the community. Heart Rhythm (2014) 0.82

Electrocardiographic and Echocardiographic Left Ventricular Hypertrophy in the Prediction of Stroke in the Elderly. J Stroke Cerebrovasc Dis (2015) 0.82

Usefulness of quantitative assessment of electrocardiographic ST depression for predicting new-onset heart failure in American Indians (from the Strong Heart Study). Am J Cardiol (2007) 0.81

Nocturnal Blood Pressure Pattern Affects Left Ventricular Remodeling and Late Gadolinium Enhancement in Patients with Hypertension and Left Ventricular Hypertrophy. PLoS One (2013) 0.81

Imaging in hypertensive heart disease. Expert Rev Cardiovasc Ther (2011) 0.81

Does a reduction in left ventricular hypertrophy reduce cardiovascular morbidity and mortality? Drugs (1992) 0.81

Echocardiographic differentiation of pathological and physiological left ventricular hypertrophy. Heart (2001) 0.81

Myocardial infarction in spontaneously hypertensive rats with superimposed adrenal-regeneration hypertension. Br J Exp Pathol (1979) 0.80

Myocardial infarction in sickle cell disease: use of translational imaging to diagnose an under-recognized problem. J Cardiovasc Transl Res (2012) 0.79

Association between Obstructive Sleep Apnea and Left Ventricular Structure by Age and Gender: the Multi-Ethnic Study of Atherosclerosis. Sleep (2016) 0.79

Genetic variants predicting left ventricular hypertrophy in a diabetic population: a Go-DARTS study including meta-analysis. Cardiovasc Diabetol (2013) 0.78

Relation between carotid intima-media thickness and left ventricular mass in type 1 diabetes mellitus (from the Epidemiology of Diabetes Interventions and Complications [EDIC] Study). Am J Cardiol (2012) 0.78

The ischemic electrocardiogram: a harbinger for ischemic heart disease independent of the blood pressure level. The Copenhagen City Heart Study. Eur J Epidemiol (2005) 0.78

Stargazing microRNA maps a new miR-21 star for cardiac hypertrophy. J Clin Invest (2014) 0.78

Does consideration of either psychological or material disadvantage improve coronary risk prediction? Prospective observational study of Scottish men. J Epidemiol Community Health (2007) 0.78

Electrocardiographic left ventricular hypertrophy predicts arrhythmia and mortality in patients with ischemic cardiomyopathy. J Interv Card Electrophysiol (2012) 0.78

Usefulness of Left Ventricular Mass and Geometry for Determining 10-Year Prediction of Cardiovascular Disease in Adults Aged >65 Years (from the Cardiovascular Health Study). Am J Cardiol (2016) 0.77

Clinical Diagnosis of Electrical Versus Anatomic Left Ventricular Hypertrophy: Prognostic and Therapeutic Implications. Circ Arrhythm Electrophysiol (2016) 0.77

Clinical implications for therapy: possible cardioprotective effects of ACE inhibition. Br J Clin Pharmacol (1989) 0.77

Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease. Cardiovasc Drugs Ther (1996) 0.77

Coronary haemodynamics in left ventricular hypertrophy. Heart (1996) 0.77

Impaired left ventricular filling in hypertensive left ventricular hypertrophy as a marker of the presence of an arrhythmogenic substrate. Br Heart J (1995) 0.77

Role of ACE inhibitors in hypertension with left ventricular hypertrophy. Br Heart J (1994) 0.77

Left ventricular area on non-contrast cardiac computed tomography as a predictor of incident heart failure - The Multi-Ethnic Study of Atherosclerosis. J Cardiovasc Comput Tomogr (2016) 0.77

Electrocardiographic left ventricular hypertrophy with strain pattern: prevalence, mechanisms and prognostic implications. Cardiovasc J Afr (2008) 0.76

Electrocardiographic Predictors of Cardiovascular Mortality. Dis Markers (2015) 0.76

The renin-angiotensin-aldosterone system and cardiac ischaemia. Heart (1996) 0.76

Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review. Drugs (1988) 0.76

Essential hypertensive vascular disease: pathogenesis and pathophysiology. Bull N Y Acad Med (1981) 0.75

Multicenter epidemiological studies of atherosclerosis imaging. Top Magn Reson Imaging (2009) 0.75

Ventricular arrhythmias in patients with myocardial infarction and ischaemia. The role of serum potassium. Drugs (1986) 0.75

Left ventricular mass index and coronary artery disease in hypertensive black males. J Natl Med Assoc (1993) 0.75

Three years' experience of electrocardiography in a general practice. J R Coll Gen Pract (1975) 0.75

What can genetic studies of left ventricular mass tell us? Circ Cardiovasc Genet (2011) 0.75

Independent Prognostic Value of Single and Multiple Non-Specific 12-Lead Electrocardiographic Findings for Long-Term Cardiovascular Outcomes: A Prospective Cohort Study. PLoS One (2016) 0.75

Editorial: Screening for presymptomatic coronary disease. Br Med J (1976) 0.75

ECG low QRS voltage and wide QRS complex predictive of centenarian 360-day mortality. Age (Dordr) (2016) 0.75

Addition of N-terminal pro-B-type natriuretic peptide levels to electrocardiography criteria for detection of left ventricular hypertrophy: the ARIRANG study. J Korean Med Sci (2015) 0.75

Letter: Renin in hypertension. Can Med Assoc J (1974) 0.75

Myocardial disorders in a Jamaican rural community. Postgrad Med J (1972) 0.75

The Romhilt-Estes electrocardiographic score predicts sudden cardiac arrest independent of left ventricular mass and ejection fraction. Ann Noninvasive Electrocardiol (2017) 0.75

Effects of different antihypertensive drugs on left ventricular function. Drugs (1988) 0.75

Pre-treatment workup for antihypertensive treatment. Drugs (1976) 0.75

Electrocardiographic Strain Pattern Is Associated With Left Ventricular Concentric Remodeling, Scar, and Mortality Over 10 Years: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc (2017) 0.75

Effects of long term treatment with pinacidil and nifedipine on left ventricular anatomy and function in patients with mild to moderate systemic hypertension. Drugs (1988) 0.75

Epidemiology and risk profile of cardiac failure. Cardiovasc Drugs Ther (1988) 0.75

Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23

Cardiovascular disease risk profiles. Am Heart J (1991) 21.65

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93

An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39

The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation (1983) 12.63

Diabetes and cardiovascular disease. The Framingham study. JAMA (1979) 11.95

An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71

Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54

The Framingham Offspring Study. Design and preliminary data. Prev Med (1975) 10.53

Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation (1989) 9.97

Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24

Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med (1982) 8.62

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09

The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01

The progression from hypertension to congestive heart failure. JAMA (1996) 7.56

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med (1971) 7.46

The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23

Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00

Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72

Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42

Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J (1986) 5.89

Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55

Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37

Diabetes and cardiovascular risk factors: the Framingham study. Circulation (1979) 5.32

Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol (1974) 5.11

Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11

A general cardiovascular risk profile: the Framingham Study. Am J Cardiol (1976) 5.10

Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol (1972) 5.05

Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med (1984) 5.02

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med (1979) 4.94

Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol (1971) 4.90

Some health benefits of physical activity. The Framingham Study. Arch Intern Med (1979) 4.63

HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation (1977) 4.47

The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis (1966) 4.15

Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J (1987) 4.12

Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA (1987) 4.05

Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99

Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79

Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care (1980) 3.70

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA (1996) 3.68

Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59

Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med (1976) 3.50

Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA (1993) 3.42

Epidemiology of coronary heart disease: the Framingham study. Am J Med (1984) 3.38

Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation (1990) 3.29

Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29

Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Br J Cancer (2001) 3.23

The recent decrease in CHD mortality. Prev Med (1975) 3.16

Premature mortality from coronary heart disease. The Framingham study. JAMA (1971) 3.15

The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med (1967) 3.05

Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93

Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med (1972) 2.91

Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med (1969) 2.88

The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease. Am J Epidemiol (1980) 2.86

Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med (1987) 2.82

Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. Lancet (1974) 2.81

Labile hypertension: a faulty concept? The Framingham study. Circulation (1980) 2.76

Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation (1975) 2.74

Hearing in the elderly: the Framingham cohort, 1983-1985. Part I. Basic audiometric test results. Ear Hear (1990) 2.71

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med (1985) 2.71

Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr (1996) 2.70

Clustering of metabolic factors and coronary heart disease. Arch Intern Med (1999) 2.69

Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA (1988) 2.68